HC Deb 03 May 2001 vol 367 c719W
Miss Geraldine Smith

To ask the Secretary of State for Defence what progress has been made on investigations into illness suffered by British troops who received the meningitis vaccine in preparation for service during the Gulf war; if the meningitis vaccine contained the Pertussis vaccine; and which company manufactured this vaccine. [159872]

Dr. Moonie

Up to around 5,000 Service personnel who deployed to the Gulf in 1990–91 may have received immunisation against meningococcal meningitis A and C. Initially, in August 1990, immunisation was recommended for all personnel who were to serve in the Gulf. However, by 15 September 1990, the immunisation was no longer recommended except for medical personnel and some other categories of personnel who may have been at risk.

Research sponsored by the Ministry of Defence has not specifically investigated a link between the meningitis vaccine and the subsequent ill health of Gulf veterans, and the Ministry of Defence is unaware of any reported association between the vaccine and subsequent ill health (with the exception of the known side effects). The meningitis vaccine did not contain the pertussis (whooping cough) vaccine.

The pertussis vaccine was used separately as part of the anti Biological Warfare immunisation programme as an adjuvant to accelerate the immunisation effect of the anthrax vaccine. There were two main suppliers of the meningitis vaccine. One supplier, Pasteur Merieux MSD, was the manufacturer of the product supplied. The other supplier was SmithKline Beecham; however we have yet to confirm the manufacturer. When we have done so, I will write to my hon. Friend and place a copy of my letter in the Library of the House.

Forward to